English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
現代牙科集團四十週年誌慶:「數字驅動 重塑笑容新標準」
Feb 13, 2026 10:36 HKT
Modern Dental Group Celebrates 40 Years: 'Redefining Smiles. The Digital Way.'
Feb 13, 2026 10:31 HKT
现代牙科集团四十周年志庆:「数字驱动 重塑笑容新标准」
Feb 13, 2026 09:40 HKT
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Feb 11, 2026 19:00 HKT
愛芯元智上市 聯控(3396.HK)旗下聯想之星開年收穫3個IPO
Feb 11, 2026 18:07 HKT
爱芯元智上市 联控(3396.HK)旗下联想之星开年收获3个IPO
Feb 11, 2026 17:48 HKT
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong
Feb 10, 2026 18:14 HKT
億勝生物參展香港2026年亞太眼科學會年會(APAO 2026)强化眼科創新承諾
Feb 10, 2026 17:52 HKT
亿胜生物参展香港2026年亚太眼科学会年会(APAO 2026)强化眼科创新承诺
Feb 10, 2026 17:32 HKT
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 06, 2026 17:45 HKT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 06, 2026 17:01 HKT
歌禮製藥-B(01672)獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 06, 2026 16:56 HKT
歌礼制药-B(01672)获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 06, 2026 16:50 HKT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 06, 2026 14:17 HKT
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 06, 2026 14:11 HKT
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 06, 2026 14:03 HKT
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 06, 2026 11:44 HKT
歌礼制药-B(01672)获新加坡政府投资公司入股6412.8万股 涉资约1亿美元
Feb 05, 2026 20:14 HKT
歌禮製藥-B(01672)獲新加坡政府投資公司入股6412.8萬股 涉資約1億美元
Feb 05, 2026 20:14 HKT
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 05, 2026 20:14 HKT
Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: